The good, the bad and the ugly of the new treatments for hepatitis C virus
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 5
Abstract
Authors and Affiliations
Karen V. Silva-Vidal, Nahum Méndez-Sánchez
Keywords
Related Articles
- EP ID EP78446
- DOI -
- Views 108
- Downloads 0
Autoimmune hepatitis with giant-cell transformation
Background/Aims: Giant-cell hepatitis (GCH), also known as postinfantile or syncytial giant cell hepatitis, is a frequent pattern of liver injury in the neonate, primarily seen in the first three months of life. Few case...
Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis
Background and aim. The effect of preoperative transcatheter arterial chemoembolization (TACE) on the short- and long-term outcome of resectable hepatocellular carcinoma (HCC) is controversial. We conducted a retrospecti...
Hepatolithiasis with secondary cholangitis and supernumerary left hepatic lobe
We report the case of a 31-year old woman with recurrent cholangitis secondary to hepatolithiasis. The stones were composed of calcium bilirrubinate. The patient also had a supernumerary hepatic lobe connected to the inf...
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...
Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy
Background and aims. Practitioners treating hepatitis C (HCV) provide healthcare to a special population with high rates of substance abuse and psychiatric disorders. We investigated the psychosocial profile in HCV patie...